Dana-Farber Cancer Institute, Inc. v. Ono Pharmaceutical Co., Ltd. et al
| Dana-Farber Cancer Institute, Inc. |
| Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons, LLC and Bristol-Myers Squibb Company |
| 1:2015cv13443 |
| September 25, 2015 |
| US District Court for the District of Massachusetts |
| Boston Office |
| Suffolk |
| Mark L. Wolf |
| Patent |
| 28 U.S.C. ยง 1338 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
389
Chief Judge Patti B. Saris: FINDINGS OF FACT, CONCLUSIONS OF LAW, AND ORDER entered.The Court enters judgment in favor of Dana-Farber. Dana-Farber shall submit a form of judgment within ten days ordering correction of the patents. SO ORDERED.(Lara, Miguel)
|
|
Filing
85
Judge Mark L. Wolf: ORDER entered. MEMORANDUM AND ORDER. Case stayed. (Bartlett, Timothy)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Massachusetts District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
